Lyson Medical Technology CO., LTD.
Update:2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
1. Head and Neck Minimally Invasive Thermal Ablation Surgery Training System
2. Transcatheter Aortic Valve Implantation (TAVI) Skills Training Platform
3. Laparoscopic Liver Minimally Invasive Surgery Training Platform
4. Mixed Reality (MR) Glasses-Guided Liver Surgery Training System
5. Breast Ultrasound, Biopsy, and Thermal Ablation Training Platform
2. Transcatheter Aortic Valve Implantation (TAVI) Skills Training Platform
3. Laparoscopic Liver Minimally Invasive Surgery Training Platform
4. Mixed Reality (MR) Glasses-Guided Liver Surgery Training System
5. Breast Ultrasound, Biopsy, and Thermal Ablation Training Platform
The content above was translated by Ai
Founded Year
2025
Unified Business No.
60702536
Status
Active
Number of Employees
0
Total Paid-in
Capital
31,420,000 (NT$)
Location of Company
Taiwan
, Tainan City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
The research team of Lyson Medical Technology CO., LTD. independently develops, manufactures, and distributes a series of medical surgical training systems that simulate real tissue characteristics. We focus on healthcare needs, are committed to providing the highest quality product lines, and are dedicated to surgical training and customized services. Our products include: anatomical models suitable for thermal ablation, realistic medical simulators, health education products, and ultrasound phantoms.
Redefining the realism of surgical technology education. We hold multiple domestic and international patents and are committed to providing high-fidelity training platforms to enhance surgical precision and the learning efficiency of surgical training.
With strong technical strength and clinical application potential, Lyson Medical Technology CO., LTD. was selected for the National Science and Technology Council's scientific research startup program and has won multiple innovation awards, demonstrating our competitive advantage in the field of precision medicine. We actively participate in industry activities and collaborations, and are committed to introducing our technology into clinical applications. The company was officially established in June 2025, and in the same month, it was invited to present at a professional medical forum, rapidly expanding its industry visibility.
Looking to the future, we will continue to promote smart precision medicine, strengthen cross-disciplinary cooperation, accelerate clinical implementation, and jointly build a highly efficient and precise new future for medicine in Asia.
Redefining the realism of surgical technology education. We hold multiple domestic and international patents and are committed to providing high-fidelity training platforms to enhance surgical precision and the learning efficiency of surgical training.
With strong technical strength and clinical application potential, Lyson Medical Technology CO., LTD. was selected for the National Science and Technology Council's scientific research startup program and has won multiple innovation awards, demonstrating our competitive advantage in the field of precision medicine. We actively participate in industry activities and collaborations, and are committed to introducing our technology into clinical applications. The company was officially established in June 2025, and in the same month, it was invited to present at a professional medical forum, rapidly expanding its industry visibility.
Looking to the future, we will continue to promote smart precision medicine, strengthen cross-disciplinary cooperation, accelerate clinical implementation, and jointly build a highly efficient and precise new future for medicine in Asia.
The content above was translated by Ai